SuperworthImmunityBio shares outstanding IBRX
Diluted shares outstanding, averaged over each quarter, from 2014.
- Latest quarter, to Jun 30, 2026
- 1.1B
- On a year earlier
- +18.2%
- more shares
ImmunityBio had 1.1B diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 18.2% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 989.7M | +35% |
| FY2024 | 733.2M | +10% |
| FY2023 | 667.8M | +65% |
| FY2022 | 403.6M | +2% |
| FY2021 | 397M | +266% |
| FY2020 | 108.6M | +10% |
| FY2019 | 98.4M | +24% |
| FY2018 | 79.2M | −0% |
| FY2017 | 79.4M | −3% |
| FY2016 | 82.2M | +1% |
| FY2015 | 81.2M | +459% |
| FY2014 | 14.5M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 1.1B | +18% | |
| Q1 FY26 | 1B | +20% | |
| Q4 FY25 | 989.7M | +35% | |
| Q3 FY25 | 946.6M | +36% | |
| Q2 FY25 | 888.2M | +29% | |
| Q1 FY25 | 853.2M | +27% | |
| Q4 FY24 | 733.2M | +10% | |
| Q3 FY24 | 698M | +40% | |
| Q2 FY24 | 686.9M | +57% | |
| Q1 FY24 | 672.8M | +57% | |
| Q4 FY23 | 667.8M | +65% | |
| Q3 FY23 | 498.4M | +25% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on ImmunityBio
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.